vs
Side-by-side financial comparison of Longeveron Inc. (LGVN) and ScanTech AI Systems Inc. (STAI). Click either name above to swap in a different company.
ScanTech AI Systems Inc. is the larger business by last-quarter revenue ($631.0K vs $365.0K, roughly 1.7× Longeveron Inc.). Longeveron Inc. runs the higher net margin — -1491.5% vs -1532.9%, a 41.4% gap on every dollar of revenue.
Longeveron Inc. is a clinical-stage biotechnology company specializing in regenerative medicine therapies for aging-related and life-threatening conditions. Its lead candidate targets geriatric frailty, Alzheimer's disease, and cardiovascular disorders, with core operations focused on the U.S. biopharmaceutical market.
LGVN vs STAI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $365.0K | $631.0K |
| Net Profit | $-5.4M | $-9.7M |
| Gross Margin | 70.4% | 27.6% |
| Operating Margin | -1479.2% | -773.2% |
| Net Margin | -1491.5% | -1532.9% |
| Revenue YoY | -39.5% | — |
| Net Profit YoY | -33.3% | — |
| EPS (diluted) | $-0.23 | $-0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $365.0K | — | ||
| Q3 25 | $137.0K | $631.0K | ||
| Q2 25 | $316.0K | $884.0K | ||
| Q1 25 | $381.0K | $346.1K | ||
| Q4 24 | $603.0K | — | ||
| Q3 24 | $773.0K | — | ||
| Q2 24 | $468.0K | — | ||
| Q1 24 | $548.0K | — |
| Q4 25 | $-5.4M | — | ||
| Q3 25 | $-7.2M | $-9.7M | ||
| Q2 25 | $-5.0M | $-6.9M | ||
| Q1 25 | $-5.0M | $-17.9M | ||
| Q4 24 | $-4.1M | — | ||
| Q3 24 | $-4.4M | — | ||
| Q2 24 | $-3.4M | — | ||
| Q1 24 | $-4.1M | — |
| Q4 25 | 70.4% | — | ||
| Q3 25 | 91.2% | 27.6% | ||
| Q2 25 | 46.2% | 14.3% | ||
| Q1 25 | 72.2% | 29.4% | ||
| Q4 24 | 87.7% | — | ||
| Q3 24 | 88.2% | — | ||
| Q2 24 | 73.5% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | -1479.2% | — | ||
| Q3 25 | -5335.8% | -773.2% | ||
| Q2 25 | -1707.9% | -440.1% | ||
| Q1 25 | -1359.8% | -4503.9% | ||
| Q4 24 | -710.3% | — | ||
| Q3 24 | -601.4% | — | ||
| Q2 24 | -747.9% | — | ||
| Q1 24 | -746.4% | — |
| Q4 25 | -1491.5% | — | ||
| Q3 25 | -5270.8% | -1532.9% | ||
| Q2 25 | -1591.1% | -785.1% | ||
| Q1 25 | -1315.2% | -5174.2% | ||
| Q4 24 | -677.1% | — | ||
| Q3 24 | -571.7% | — | ||
| Q2 24 | -729.3% | — | ||
| Q1 24 | -740.5% | — |
| Q4 25 | $-0.23 | — | ||
| Q3 25 | $-0.39 | $-0.16 | ||
| Q2 25 | $-0.33 | $-0.16 | ||
| Q1 25 | $-0.34 | $-0.77 | ||
| Q4 24 | $1.16 | — | ||
| Q3 24 | $-0.34 | — | ||
| Q2 24 | $-1.83 | — | ||
| Q1 24 | $-1.61 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.7M | — |
| Total DebtLower is stronger | — | $17.7M |
| Stockholders' EquityBook value | $5.7M | — |
| Total Assets | $10.3M | $5.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.7M | — | ||
| Q3 25 | $9.2M | — | ||
| Q2 25 | $10.3M | — | ||
| Q1 25 | $14.3M | — | ||
| Q4 24 | $19.2M | — | ||
| Q3 24 | $22.8M | — | ||
| Q2 24 | $12.4M | — | ||
| Q1 24 | $2.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $17.7M | ||
| Q2 25 | — | $17.7M | ||
| Q1 25 | — | $17.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $5.7M | — | ||
| Q3 25 | $10.0M | — | ||
| Q2 25 | $12.7M | — | ||
| Q1 25 | $17.2M | — | ||
| Q4 24 | $21.9M | — | ||
| Q3 24 | $25.6M | — | ||
| Q2 24 | $14.9M | — | ||
| Q1 24 | $3.0M | — |
| Q4 25 | $10.3M | — | ||
| Q3 25 | $15.6M | $5.1M | ||
| Q2 25 | $16.7M | $4.6M | ||
| Q1 25 | $20.8M | $5.1M | ||
| Q4 24 | $25.6M | — | ||
| Q3 24 | $29.9M | — | ||
| Q2 24 | $19.4M | — | ||
| Q1 24 | $9.7M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $-758.5K |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | — | ||
| Q3 25 | $-5.1M | $-758.5K | ||
| Q2 25 | $-3.6M | $-1.5M | ||
| Q1 25 | $-4.7M | $-2.2M | ||
| Q4 24 | $-3.4M | — | ||
| Q3 24 | $-2.8M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-3.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | $-5.1M | — | ||
| Q2 25 | $-3.8M | $-1.5M | ||
| Q1 25 | $-4.7M | $-2.2M | ||
| Q4 24 | $-3.4M | — | ||
| Q3 24 | $-3.3M | — | ||
| Q2 24 | $-4.8M | — | ||
| Q1 24 | $-3.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | -3731.4% | — | ||
| Q2 25 | -1189.2% | -166.0% | ||
| Q1 25 | -1239.9% | -623.8% | ||
| Q4 24 | -561.5% | — | ||
| Q3 24 | -423.4% | — | ||
| Q2 24 | -1017.5% | — | ||
| Q1 24 | -566.1% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 41.6% | 0.0% | ||
| Q2 25 | 50.9% | 1.0% | ||
| Q1 25 | 7.1% | 2.0% | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 55.6% | — | ||
| Q2 24 | 41.9% | — | ||
| Q1 24 | 2.9% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
